Cargando…
Fenofibrate potentiates chemosensitivity to human breast cancer cells by modulating apoptosis via AKT/NF-κB pathway
BACKGROUND: Cumulatively, evidences revealed that fenofibrate used in the therapy of hyperlipidemia and hypercholesterolemia has anti-cancer effect in multiple cancer types. However, its function and underlying mechanism of chemosensitization in breast cancer remain poorly understood. MATERIALS AND...
Autores principales: | Sun, Jianguo, Zheng, Zhibao, Chen, Qi, Pan, Yin, Quan, Mingming, Dai, Yuechu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353220/ https://www.ncbi.nlm.nih.gov/pubmed/30774365 http://dx.doi.org/10.2147/OTT.S191239 |
Ejemplares similares
-
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
por: Li, Ting, et al.
Publicado: (2014) -
NRF3 suppresses breast cancer cell metastasis and cell proliferation and is a favorable predictor of survival in breast cancer
por: Sun, Jianguo, et al.
Publicado: (2019) -
Dexamethasone affects cell growth/apoptosis/chemosensitivity of colon cancer via glucocorticoid receptor α/NF-κB
por: He, Jianming, et al.
Publicado: (2017) -
NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells
por: Han, Dongfeng, et al.
Publicado: (2015) -
Inactivation of AKT/NF-κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin
por: Dukaew, Nahathai, et al.
Publicado: (2020)